Clinical Trial Update: Haploidentical Natural Killer (NK) Cells in Patients With Relapsed or Refractory Neuroblastoma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating haploidentical natural killer cells in patients with relapsed or refractory neuroblastoma has been terminated; results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• haploidentical natural killer (NK) cells (natural killer cells)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Neuroblastoma | Phase 2 | Status: TERMINATED | Results posted: 2012-11-22